'Going Viral: The Inside Story of Covaxin', written by ICMR DG Dr Balram Bhargava, was handed over to WHO and UN officials by the author during an event at UNAIDS office in Geneva.
The proposed trial can be on people who either have not been vaccinated or who already received two doses of an mRNA vaccine at least six months earlier in the US.
WHO official Dr Margaret Harris said the technical advisory group that reviews all the data for a potential emergency use listing is studying Covaxin today (26 October).
Long wait for Covaxin’s emergency-use listing has perplexed many. The issue was discussed at great length during Health Minister Mansukh Mandaviya’s meeting with WHO Director-General Tuesday.
During a call, WHO chief Tedros Adhanom Ghebreyesus and Health Minister Mansukh Mandaviya also discussed the resumption of supply of Covishield to COVAX facility.
Bharat Biotech had last month said it has submitted all data pertaining to Covaxin to the WHO for emergency use and is awaiting feedback from the global health watchdog.
Currently, three vaccines — Covishield, Covaxin and Sputnik V — being administered in the country are only for those above 18 years of age. All of them are two-dose vaccines.
For Chinese commentators, India’s careful steps reveal a country navigating the rise of China cautiously and pragmatically, with its own interests firmly in mind.
New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.
Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
COMMENTS